You need to do a little reading.
"An antigen-presenting cell (APC) or accessory cell is a cell that displays foreign antigen complex with MHC on its surface. T-cells may recognize this complex using their T-cell receptor (TCR)"
Look at it this way, T-cells are your body's soldiers, and they attack bad foreign stuff like viruses, bacteria, toxins etc.-antigens. The APC cells encounter these intruders/antigens and present them to the soldiers-Shoot these suckers, right away! They call the APC's that are really good at doing their job, professional APCs. Cel-Sci has apparently created the equivalent of a very professional APC, in the form of their proprietary synthetic peptide T-cell binding ligand. They also construct synthetic peptides to represent the target antigen. Put the two together and you have the LEAPS construct. Some more reading, sorry:
"The concept behind the L.E.A.P.S.™ technology is to directly mimic cell/cell interactions on the T-cell surface with synthetic peptides. The L.E.A.P.S™ constructs containing the antigenic disease epitope linked to a T-cell binding ligand (TCBL) can be manufactured by peptide synthesis or by covalently linking the two peptides."
So LEAPS constructs mimic the APCs presentation of the antigen/enemy to the soldier T-cells. And they may do a better job of it than the body's own professional APCs. That's why the government is all over this.
This is where it really get's interesting lance:
"Any disease for which an antigenic sequence has been identified such as: infectious, parasitic, malignant or autoimmune diseases and allergies are potential therapeutic or preventive sites for the application of L.E.A.P.S.™ technology."
Thanks for your logical insight. My wife's field is in Molecular Diagnostics. She gets it! AND she encouraged me to acquire shares in CVM. She fully expects FDA to give EUA approval very soon based on what she see in the field. The hospitals and labs are gearing up quickly for a large influx of H1N1 cases. They are concerned about the patients that are not responding to normal treatement.
Finally someone who gets why this is a bargain stock, and why it will be a game changer in modern medicine. I guess those Wall St types are still trying to figure out how to make money trading Google and Apple, as they haven't caught on to this break through and what it really means. This is why Cel-Sci has constructed a customer facility. This is not about cancer or H1N1, but about how to treat/prevent any viral infection.